期刊文献+

依那普利片与硝苯地平缓释片降压疗效对比

Enalapril tablet and Nifedipine Sustained Release Tablets antihypertensive effects of contrast
下载PDF
导出
摘要 目的观察依那普利片与硝苯地平缓释片对1级、2级原发性高血压的降压疗效。方法 79例原发性高血压患者分为治疗组41例和对照组38例,治疗组服用依那普利片,对照组服用硝苯地平缓释片,观察15 d及30 d后对2组降压疗效进行对比分析。结果依那普利片降压疗效优于硝苯地平缓释片,但差异无显著性(P>0.05)。结论依那普利片与硝苯地平缓释片均可以作为降压的首选药物,但是对于2级以上高血压病例宜小剂量药物联合应用。 Objective Enahpril tablet and Nifedipine Sustained Release Tablets for level 1, level 2 primary hypertension disease hypertension treatment Observation. Methods 79 cases of primary hypertension were divided into treatment group 41 cases and control group of 38 cases, the treatment group was treated with enahpril, the control group was treated with nifedipine sustained-release tablets, the antihypertensive effect in the 2 groups were observed. The antihypertensive effect was comparatively analyzed after 15 days and 30 days. Results Enalapril antihypertensive effect was better than that of nifedipine sustained-release tablets, but the difference was not significant (P〉0.05). Conclusion Enalapril and nifedipine sustained-release tablets can be used as the first choice of antihypertensive drug, but for more than 2 levels of hypertension should get combined with small doses of the two drugs.
出处 《基层医学论坛》 2013年第4期425-426,共2页 The Medical Forum
关键词 高血压 靶器官 依那普利片 硝苯地平缓释片 Hypertension Target organs Enalapril tablet Nifedipine sustained release tablets
  • 相关文献

参考文献2

二级参考文献19

  • 1黄敏,刘晖,冼志莲.门诊降压药物应用调查分析[J].现代医药卫生,2006,22(14):2231-2231. 被引量:3
  • 2韩华清,贾桂仙,邬冬梅,赵耿明.施慧达治疗原发性高血压30例疗效观察[J].临床医药实践,2006,15(12):895-896. 被引量:7
  • 3金良彪.北京地区抗高血压药概述[J].中国医药荟萃,1995,6(1):7-7.
  • 4[2]Chobanian AV,Bakfis GL.The Seventh Report of the Joint National Committee on the Detection,Evaluation,and Treatment of High Blood Presgure:the JNC 7 report[J].JAMA,2003,289:2560-2572
  • 5[3]ALLHAT Collaborative Research Group.Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic:the ALL HAT[J].JAMA,2002,288:1981-1997
  • 6[4]Setaro JF,Black HR.Refractory hypertension[J].N Engl J Med,1992,327:543-547
  • 7[5]Cushman WC,Ford CE,Cutler JA,et al.Success and predictors of blood pressure control in diverse North American settings:the ALL HAT[J].J Chin Hypertens,2002,4:393-404
  • 8[6]Black HR,ElliottWJ,Grandits G,et al.Principal results of Controlled Onset Verapamil Investigation of Cardiovascular End Points(CON VINCE)Trial.JAMA,2003,289,2073-2082
  • 9[7]Julius S,Kjeldsen SE,Brunner H,et al.VALUE trial:long-term blood pressure trends in 13449 patients with hypertension and high car diovascurlar risk[J].Am J Hypertens,2003,16:544-548
  • 10[8]Messerli FH,Ventura HO,Amodeo C.Osier's nlaneuver and pseudo hypertension[J].N Engl J Med,1985,312:1548-1551

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部